-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
▎WuXi AppTec content team edits cancer, the most common cause of death worldwide
.
In 2020, there will be 19.
3 million new cases of cancer worldwide, resulting in nearly 10 million deaths; 1 in 5 people will develop cancer in their lifetime; 1 in 8 men and 1 in 11 women will died of cancer
.
Fortunately, advances in cancer research, prevention, treatment, and care have led to marked reductions in cancer incidence and mortality in some countries
.
What is the current status and trend of cancer incidence and mortality in China? What other factors are affecting? What measures should we take to reduce cancer morbidity and mortality? In response to these questions, researchers from the National Cancer Center of China/Tumor Hospital of the Chinese Academy of Medical Sciences conducted a study
.
The research results were published in the Chinese Medical Journal (English version), and the corresponding author is Professor Chen Wanqing
.
Image source: 123RF The results of this study show that in 2022, there will be about 4.
82 million new cancer cases in China, resulting in 3.
21 million deaths; the burden of liver, gastric and esophageal cancer in China will decrease, but lung, colorectal, breast and Increased burden on the prostate; advances in cancer prevention and care, as well as aggressive responses to population aging, may help reduce cancer burden in China
.
Common new cancers and deaths in China in 2022 Researchers predict that in 2022, there will be about 4.
82 million new cancer cases and 3.
21 million deaths due to cancer in China
.
Lung cancer remains the most common new cancer and the leading cause of death
.
In 2022, the 5 most common new cancers are lung cancer (870,000), colorectal cancer (590,000), stomach cancer (510,000), liver cancer (430,000) and breast cancer (430,000); the 5 most common cancers that cause death It is lung cancer (770,000), liver cancer (410,000), stomach cancer (400,000), esophagus cancer (320,000) and colorectal cancer (310,000)
.
The number of new cancers and deaths is significantly higher in men than in women, and the types of common new and dying cancers vary widely
.
Among men, 2.
63 million new cancers are expected, resulting in 1.
94 million deaths
.
The most common new cancers were lung cancer (580,000), stomach cancer (350,000), colorectal cancer (340,000), liver cancer (320,000) and esophagus (240,000)
.
The most common causes of cancer deaths were lung cancer (510,000), liver cancer (300,000), stomach cancer (270,000), esophagus (220,000) and colorectal cancer (180,000)
.
Among women, 2.
2 million new cancers are expected, resulting in 1.
26 million deaths
.
The most common new cancers were breast cancer (430,000), lung cancer (300,000), colorectal cancer (250,000), thyroid cancer (170,000) and stomach cancer (160,000)
.
The most common causes of cancer deaths were lung cancer (260,000), colorectal cancer (130,000), stomach cancer (130,000), breast cancer (120,000) and liver cancer (110,000)
.
Image source: 123RF Cancer incidence, mortality trends and influencing factors Since 2000, the number of new cancers and deaths in China has gradually increased
.
Overall, China's cancer spectrum is in the transition stage from developing countries to developed countries, which is characterized by high incidences of lung, colorectal, breast and prostate cancers
.
The researchers believe that the increase in morbidity and mortality is strongly linked to factors such as changes in life>
.
In both men and women, the incidence and mortality of gastric, liver, and esophageal cancers have gradually decreased in recent years
.
However, the incidence of colorectal and prostate cancers has increased significantly in men; in women, since 2000, seven cancers including breast, lung, colorectal, thyroid, cervical, pancreatic and ovarian cancers have The incidence of common cancers has increased
.
It should be noted that since 2000, although the mortality rate of thyroid cancer in China has remained stable, the incidence rate has increased sharply
.
Researchers believe this is related to increased health awareness, more people undergoing tests such as neck ultrasounds, and more sophisticated testing equipment
.
At the same time, the 5-year relative survival rate of cancer patients has been increasing, from 30.
9% in 2003-2005 to 40.
5% in 2012-2015, which is in line with improvements in early cancer prevention, screening, and treatment options.
very related
.
However, compared with other developed countries, the survival rate of some specific types of cancer still needs to be improved, such as breast cancer and colorectal cancer
.
Image source: How 123RF can reduce cancer morbidity and mortality Research indicates that population aging is likely to be a major social feature in China for the foreseeable future
.
China has one of the fastest growing aging populations in the world
.
As of the end of 2020, China's population aged 60 and above is 260 million, and it is expected to increase by about 10 million per year from 2021 to 2025.
By 2035, the proportion of the population aged 60 and above will exceed 30%
.
The ageing population continues to intensify, meaning that the rising cancer burden in China is likely to remain unchanged
.
Therefore, there is a need to integrate healthy ageing strategies into cancer prevention and strengthen multisectoral collaboration in policy development
.
The cancer spectrum in China is changing, so high-risk groups aged 45-74 should participate in the early screening and detection of cancers, such as colorectal cancer, breast cancer, lung cancer, cervical cancer and upper gastrointestinal cancer
.
All should adhere to primary cancer prevention measures
.
Among Chinese adults aged 20 and older, approximately 45.
2% of cancer deaths can be attributed to 23 modifiable risk factors in 5 categories, including: 4 behavioral factors, smoking, secondhand smoke, alcohol consumption, and physical inactivity; 7 dietary factors, low fruit consumption, low vegetable consumption, low dietary fiber intake, high red meat consumption, insufficient dietary calcium intake, high processed meat consumption, and high preserved vegetable consumption; 2 metabolic Factors, overweight and obesity, diabetes; 2 environmental factors, UV exposure and PM2.
5 air pollution; 8 infectious factors, Helicobacter pylori, hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), human papillomavirus (HPV), Epstein-Barr virus (EBV), Clonorchis sinensis and human herpesvirus 8 (HHV-8)
.
Targeting these 23 modifiable risk factors, adhering to primary cancer prevention measures to control behavioral, dietary, metabolic and environmental factors to prevent infection will have great potential and role in reducing cancer incidence and mortality
.
Take a comprehensive strategy
.
Taking cervical cancer as an example, the World Health Organization believes that cervical cancer is expected to become the first cancer to be eliminated worldwide
.
However, the incidence and mortality of cervical cancer in China have increased significantly since 2000
.
Therefore, we adopt a comprehensive strategy, including HPV vaccination, cervical screening, treatment of preinvasive lesions and invasive cancer, etc.
, to achieve the goal of eliminating cervical cancer
.
Image source: 123RF Summary Researchers pointed out that the number of new cancers and deaths in China is increasing, and targeted cancer interventions are urgently needed
.
In addition to focusing on and responding to an aging population and initiating research on certain cancers, more and more comprehensive prevention strategies should be implemented, including health education, dissemination of basic knowledge about cancer, promotion of healthy life>
.
Recommended reading Why do you cough? What medicine should I take when I have a cough? An article summarizing sleep sweating is also a disease? The truth has something to do with this food.
.
.
Drinking less alcohol can soften blood vessels? Every time you drink an extra sip, there may be one more "bad" heart and blood vessels in the world.
What are the advantages and disadvantages of low-sugar foods? What is the difference between the 3 truths about sugar substitutes? New crown antigen detection and nucleic acid detection? 5 questions explained at a time! Reference [1] Xia, Changfa, et al.
, (2022).
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
Chinese Medical Journal, DOI: 10.
1097/CM9.
0000000000002108.
[2] Cancer incidence in China and the USA: Scientists discuss changing and converging trends.
Retrieved Apr 1 ,2022, from https://medicalxpress.
com/news/2022-03-cancer-incidence-china-usa-scientists.
htmlDisclaimer:Medical The content team of Mingkant focuses on introducing the progress of global biomedical health research
.
This article is for information exchange purposes only, and the views expressed in this article do not represent WuXi AppTec's position, nor do they represent WuXi AppTec's support or opposition to the views expressed in this article
.
This article is also not a treatment plan recommendation
.
For guidance on treatment options, please visit a regular hospital
.
.
In 2020, there will be 19.
3 million new cases of cancer worldwide, resulting in nearly 10 million deaths; 1 in 5 people will develop cancer in their lifetime; 1 in 8 men and 1 in 11 women will died of cancer
.
Fortunately, advances in cancer research, prevention, treatment, and care have led to marked reductions in cancer incidence and mortality in some countries
.
What is the current status and trend of cancer incidence and mortality in China? What other factors are affecting? What measures should we take to reduce cancer morbidity and mortality? In response to these questions, researchers from the National Cancer Center of China/Tumor Hospital of the Chinese Academy of Medical Sciences conducted a study
.
The research results were published in the Chinese Medical Journal (English version), and the corresponding author is Professor Chen Wanqing
.
Image source: 123RF The results of this study show that in 2022, there will be about 4.
82 million new cancer cases in China, resulting in 3.
21 million deaths; the burden of liver, gastric and esophageal cancer in China will decrease, but lung, colorectal, breast and Increased burden on the prostate; advances in cancer prevention and care, as well as aggressive responses to population aging, may help reduce cancer burden in China
.
Common new cancers and deaths in China in 2022 Researchers predict that in 2022, there will be about 4.
82 million new cancer cases and 3.
21 million deaths due to cancer in China
.
Lung cancer remains the most common new cancer and the leading cause of death
.
In 2022, the 5 most common new cancers are lung cancer (870,000), colorectal cancer (590,000), stomach cancer (510,000), liver cancer (430,000) and breast cancer (430,000); the 5 most common cancers that cause death It is lung cancer (770,000), liver cancer (410,000), stomach cancer (400,000), esophagus cancer (320,000) and colorectal cancer (310,000)
.
The number of new cancers and deaths is significantly higher in men than in women, and the types of common new and dying cancers vary widely
.
Among men, 2.
63 million new cancers are expected, resulting in 1.
94 million deaths
.
The most common new cancers were lung cancer (580,000), stomach cancer (350,000), colorectal cancer (340,000), liver cancer (320,000) and esophagus (240,000)
.
The most common causes of cancer deaths were lung cancer (510,000), liver cancer (300,000), stomach cancer (270,000), esophagus (220,000) and colorectal cancer (180,000)
.
Among women, 2.
2 million new cancers are expected, resulting in 1.
26 million deaths
.
The most common new cancers were breast cancer (430,000), lung cancer (300,000), colorectal cancer (250,000), thyroid cancer (170,000) and stomach cancer (160,000)
.
The most common causes of cancer deaths were lung cancer (260,000), colorectal cancer (130,000), stomach cancer (130,000), breast cancer (120,000) and liver cancer (110,000)
.
Image source: 123RF Cancer incidence, mortality trends and influencing factors Since 2000, the number of new cancers and deaths in China has gradually increased
.
Overall, China's cancer spectrum is in the transition stage from developing countries to developed countries, which is characterized by high incidences of lung, colorectal, breast and prostate cancers
.
The researchers believe that the increase in morbidity and mortality is strongly linked to factors such as changes in life>
.
In both men and women, the incidence and mortality of gastric, liver, and esophageal cancers have gradually decreased in recent years
.
However, the incidence of colorectal and prostate cancers has increased significantly in men; in women, since 2000, seven cancers including breast, lung, colorectal, thyroid, cervical, pancreatic and ovarian cancers have The incidence of common cancers has increased
.
It should be noted that since 2000, although the mortality rate of thyroid cancer in China has remained stable, the incidence rate has increased sharply
.
Researchers believe this is related to increased health awareness, more people undergoing tests such as neck ultrasounds, and more sophisticated testing equipment
.
At the same time, the 5-year relative survival rate of cancer patients has been increasing, from 30.
9% in 2003-2005 to 40.
5% in 2012-2015, which is in line with improvements in early cancer prevention, screening, and treatment options.
very related
.
However, compared with other developed countries, the survival rate of some specific types of cancer still needs to be improved, such as breast cancer and colorectal cancer
.
Image source: How 123RF can reduce cancer morbidity and mortality Research indicates that population aging is likely to be a major social feature in China for the foreseeable future
.
China has one of the fastest growing aging populations in the world
.
As of the end of 2020, China's population aged 60 and above is 260 million, and it is expected to increase by about 10 million per year from 2021 to 2025.
By 2035, the proportion of the population aged 60 and above will exceed 30%
.
The ageing population continues to intensify, meaning that the rising cancer burden in China is likely to remain unchanged
.
Therefore, there is a need to integrate healthy ageing strategies into cancer prevention and strengthen multisectoral collaboration in policy development
.
The cancer spectrum in China is changing, so high-risk groups aged 45-74 should participate in the early screening and detection of cancers, such as colorectal cancer, breast cancer, lung cancer, cervical cancer and upper gastrointestinal cancer
.
All should adhere to primary cancer prevention measures
.
Among Chinese adults aged 20 and older, approximately 45.
2% of cancer deaths can be attributed to 23 modifiable risk factors in 5 categories, including: 4 behavioral factors, smoking, secondhand smoke, alcohol consumption, and physical inactivity; 7 dietary factors, low fruit consumption, low vegetable consumption, low dietary fiber intake, high red meat consumption, insufficient dietary calcium intake, high processed meat consumption, and high preserved vegetable consumption; 2 metabolic Factors, overweight and obesity, diabetes; 2 environmental factors, UV exposure and PM2.
5 air pollution; 8 infectious factors, Helicobacter pylori, hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), human papillomavirus (HPV), Epstein-Barr virus (EBV), Clonorchis sinensis and human herpesvirus 8 (HHV-8)
.
Targeting these 23 modifiable risk factors, adhering to primary cancer prevention measures to control behavioral, dietary, metabolic and environmental factors to prevent infection will have great potential and role in reducing cancer incidence and mortality
.
Take a comprehensive strategy
.
Taking cervical cancer as an example, the World Health Organization believes that cervical cancer is expected to become the first cancer to be eliminated worldwide
.
However, the incidence and mortality of cervical cancer in China have increased significantly since 2000
.
Therefore, we adopt a comprehensive strategy, including HPV vaccination, cervical screening, treatment of preinvasive lesions and invasive cancer, etc.
, to achieve the goal of eliminating cervical cancer
.
Image source: 123RF Summary Researchers pointed out that the number of new cancers and deaths in China is increasing, and targeted cancer interventions are urgently needed
.
In addition to focusing on and responding to an aging population and initiating research on certain cancers, more and more comprehensive prevention strategies should be implemented, including health education, dissemination of basic knowledge about cancer, promotion of healthy life>
.
Recommended reading Why do you cough? What medicine should I take when I have a cough? An article summarizing sleep sweating is also a disease? The truth has something to do with this food.
.
.
Drinking less alcohol can soften blood vessels? Every time you drink an extra sip, there may be one more "bad" heart and blood vessels in the world.
What are the advantages and disadvantages of low-sugar foods? What is the difference between the 3 truths about sugar substitutes? New crown antigen detection and nucleic acid detection? 5 questions explained at a time! Reference [1] Xia, Changfa, et al.
, (2022).
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
Chinese Medical Journal, DOI: 10.
1097/CM9.
0000000000002108.
[2] Cancer incidence in China and the USA: Scientists discuss changing and converging trends.
Retrieved Apr 1 ,2022, from https://medicalxpress.
com/news/2022-03-cancer-incidence-china-usa-scientists.
htmlDisclaimer:Medical The content team of Mingkant focuses on introducing the progress of global biomedical health research
.
This article is for information exchange purposes only, and the views expressed in this article do not represent WuXi AppTec's position, nor do they represent WuXi AppTec's support or opposition to the views expressed in this article
.
This article is also not a treatment plan recommendation
.
For guidance on treatment options, please visit a regular hospital
.
